Paykel-backed NZ serum exporter snaps up Aussie rival

Paykel-backed NZ serum exporter snaps up Aussie rival
Acquiring CellSera adds a 'critical new serum' to the Auckland firm’s existing product range. (Photo: supplied)
Dan Brunskill
Animal serum and plasma exporter Auckland BioSciences (ABS) has purchased an Australian competitor as it seeks to become a global industry leader.The company manufactures and exports premium New Zealand-made animal-derived serum and plasma, which are key ingredients for growing cells for bio-pharmaceutical manufacturing and medical research. While it’s not a glamourous export, this serum is vital to biotech research and the production of vaccines – including some for covid-19.“While our business is operationally complex,...

More Markets

NZ sharemarket gains as Fletcher hands over NZICC
Markets

NZ sharemarket gains as Fletcher hands over NZICC

Market leader Fisher & Paykel Healthcare was up 25c. 

Trade Me parent company appoints Owen Wilson as director
Finance

Trade Me parent company appoints Owen Wilson as director

Wilson was CE of $A30b Australian digital-property company Rea Group Ltd.

Me Today’s $2.2m capital raise ‘exceeds expectations’
Markets

Me Today’s $2.2m capital raise ‘exceeds expectations’

The company’s two largest shareholders chipped in $1.5m.

Being AI’s bold plan: No business, still listed
Markets

Being AI’s bold plan: No business, still listed

From wannabe Google challenger to now selling off its last business to escape debt.